Search Results

fruitful research space has led to more than 700 approved drugs over previous decades—but the two-year-old biotech

Since then, Celniker has helped usher in an additional fund and headed a few startups as interim CEO. That money has gone to some 60 biotechs, much of it as early funding."

spots in your drug evaluation process, moving beyond simple potency measures to understand the dynamic interactions GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

I've seen this pattern unfold across biotech, academia, and nonprofits. The assays are running, data is flowing in from your CROs or your internal labs , yet progress stalls Internal data and CRO outputs  misaligned with strategic goals.

Our partner, Domain Therapeutics, will attend the SACHS 23rd annual biotech event in Europe. Dr. Therapeutics CEO Pascal Neuville to Discuss Game-Changing GPCR-Targeting Immunotherapies at Sachs Associates' Biotech Conference November 20 - 23, 2023 | ASCEPT Annual Scientific Meeting February 3 - 7, 2024 | SLAS2024 International

(“Inversago”), a clinical stage biotech company with a unique portfolio of CB1 inverse agonists, announced

Industry News Biotech startup Structure pulls off rare IPO, raising $161M 3-drug combo leads to 'unprecedented Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) arcoscreen is one of the 13 biotech SLAS2023 International Conference and Exhibition (February 25 - March 1, 2023). 2nd ERNEST Training School

For drug hunters working at the GPCR interface, the difference between a successful lead and a dead-end Kenakin Content trusted by biotech, pharma & academia 💎 $2999/year — one conference cost = a full If you’re still treating orthosteric and allosteric interactions as interchangeable, you’re leaving precision

Martin Marro shares hard-earned lessons from the interface of assays, bias, and translation. The conversation moves beyond theory into real-world tradeoffs: fluorescence-based assays, internalization GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

Updates in GPCR Research GproteinDb in 2024: new G protein-GPCR couplings, AlphaFold2-multimer models and interface interactions Experimental modulation of physiological force application on leg joint neurons in intact Showcases Innovative AI-Driven Drug Design at BRIC AI 2023 Workshop Salipro Biotech AB Celebrates Milestones Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk February 3 - 7, 2024 | SLAS2024 International

GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

unanswered questions about blockbuster weight-loss drugs Transforming Drug Discovery: Insights from Viva Biotech's Meeting 2025 May 12 - 15, 2025 | PEGS 2025 May 20 - 22, 2025 | SLAS Europe 2025 June 16 - 19, 2025 | BIO International

incretin biology depends on more than ligand potency — it hinges on where receptors actually are, how they internalize how his team uses fluorescence tools and chemically engineered ligands to map receptor distribution, internalization datasets, balancing innovation with assay rigor, or working across chemistry–pharmacology–physiology interfaces GPCR scientists, translational pharmacologists, biotech discovery teams, and decision-makers who need

epithelial proliferation, migration, and cellular respiration Spatiotemporal Optical Control of Gαq-PLCβ Interactions Biotherapeutics in Idiopathic Pulmonary Fibrosis Former execs from Pfizer obesity drug program have started a new biotech Meetings, and Webinars January 16 - 19, 2024 | 23rd Annual PEP Talk February 3 - 7, 2024 | SLAS2024 International

the Classified GPCR News from March 25th to March 31st, 2024 GPCR Activation and Signaling PACAP key interactions Secures VLAIO Grant Supporting Drug Discovery & Development In Endocrine And Metabolic Diseases How biotech Clinical Pharmacology 2026 GPCR Jobs Postdoctoral Associate Research Technologist I Senior Scientist- Internal

curriculum with your topic suggestions Weekly new releases  to stay ahead of the science Content built for biotech

Surveying nonvisual arrestins reveals allosteric interactions between functional sites. of Alcohol and Substance Use Disorders AbbVie recruits a GPCR team in Oxford, buying out a fledgling biotech

To solve this industry-wide problem, Orion Biotechnology (Orion) is introducing a novel solution driven technological advances related to the understanding of structure and activation mechanisms of GPCRs, the biotech investment community has injected significant funding into small biotech companies developing novel About Orion Biotechnology Orion’s mission is to unlock the therapeutic potential of previously undruggable For more information, follow Orion Biotechnology on LinkedIn or visit www.orionbiotechnology.com.

26RFa by the pyroglutamylated RFamide peptide receptor Industry News NanoImaging Services and Cube Biotech

GPCR scientists, translational pharmacologists, biotech discovery teams, platform company leaders, and

Mid-2025 How GPCR agonists, including antibodies, are shaping the future of metabolic care Salipro Biotech Meeting 2025 May 12 - 15, 2025 | PEGS 2025 May 20 - 22, 2025 | SLAS Europe 2025 June 16 - 19, 2025 | BIO International assemble the ternary parathyroid hormone-GPCR-arrestin complex Myosin VI drives arrestin-independent internalization

Industry News Orion Biotechnology at the AACR 2023. (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) NEW ASPET 2023 - American Society for Pharmacology

Visit in its clinical phase 2b trial with AEF0117 for the treatment of cannabis use disorder Orion Biotechnology will be presenting at the 19th Biopharma Drug Discovery Nexus Salipro Biotech will participate in BioKorea2024 Research Technologies Novo Nordisk Postdoctoral Associate Research Technologist I Senior Scientist- Internal

Reviews, GPCRs, and more Internal and external modulation factors of the orexin system (REVIEW). (April 20 - 21, 2023) Swiss Biotech Day (April 24 - 25, 2023) ASPET 2023 - American Society for Pharmacology

Tom Sakmar didn’t set out to map GPCR-RAMP interactions across hundreds of receptors. technology and collaborators at SciLifeLab in Sweden , the lab built a multiplex assay  to study dozens of interactions  (DUET constructs), now publicly available via Addgene , and an online platform to query GPCR-RAMP interaction shift in how GPCR biology is approached : Study known & orphan GPCRs Identify new accessory protein interactions importantly, it’s free to academics , built for the community. ________________ Keyword Cloud : GPCR-RAMP interactions

(April 20 - 21, 2023) NEW Swiss Biotech Day (April 24 - 25, 2023) SLAS Europe 2023 Conference and Exhibition

Industry News Josephine (Pina) Cardarelli from GPCR Therapeutics on Beyond Biotech Podcast Crinetics

in Upcoming Investor and Industry Conferences Sosei and IPJ to become Nxera Pharma from April Orion Biotechnology will be at the BIO CEO & Investor Conference Salipro Biotech AB will be at the Oxford Global’s Biologics 2026 | 20th World Congress of Basic and Clinical Pharmacology 2026 GPCR Jobs NEW Senior Scientist- Internal

to pharmacology or brushing up on basics, this lesson will change how you think about the very first interaction Instead, it involves a dynamic interaction between the drug and the receptor. The receptor may change shape upon binding, affecting how the drug interacts and how effective it will It goes beyond simple interactions. Understanding the intricate details of drug-receptor interactions transforms how we approach pharmacology

July 2022 "Orion Biotechnology and Peptilogics are pursuing AI-driven drug discovery to explore new functional